Riverhead Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $2.76M | Buy |
16,303
+4,595
| +39% | +$778K | 0.1% | 258 |
|
|
2019
Q2 | $2.15M | Buy |
11,708
+2,274
| +24% | +$417K | 0.08% | 328 |
|
|
2019
Q1 | $1.74M | Buy |
9,434
+1,102
| +13% | +$203K | 0.07% | 341 |
|
|
2018
Q4 | $1.38M | Sell |
8,332
-662
| -7% | -$110K | 0.06% | 360 |
|
|
2018
Q3 | $1.73M | Buy |
8,994
+90
| +1% | +$17.3K | 0.06% | 346 |
|
|
2018
Q2 | $1.51M | Buy |
8,904
+1,713
| +24% | +$291K | 0.06% | 364 |
|
|
2018
Q1 | $1.17M | Buy |
7,191
+650
| +10% | +$106K | 0.05% | 388 |
|
|
2017
Q4 | $980K | Buy |
6,541
+1,062
| +19% | +$159K | 0.04% | 438 |
|
|
2017
Q3 | $833K | Sell |
5,479
-1,350
| -20% | -$205K | 0.04% | 450 |
|
|
2017
Q2 | $880K | Sell |
6,829
-708
| -9% | -$91.2K | 0.04% | 415 |
|
|
2017
Q1 | $824K | Buy |
7,537
+2,158
| +40% | +$236K | 0.05% | 408 |
|
|
2016
Q4 | $396K | Hold |
5,379
| – | – | 0.02% | 556 |
|
|
2016
Q3 | $469K | Sell |
5,379
-20,552
| -79% | -$1.79M | 0.03% | 480 |
|
|
2016
Q2 | $2.1M | Sell |
25,931
-3,400
| -12% | -$276K | 0.07% | 305 |
|
|
2016
Q1 | $2.33M | Sell |
29,331
-12,268
| -29% | -$975K | 0.03% | 490 |
|
|
2015
Q4 | $5.24M | Buy |
41,599
+900
| +2% | +$113K | 0.08% | 318 |
|
|
2015
Q3 | $4.24M | Sell |
40,699
-1,263
| -3% | -$132K | 0.07% | 330 |
|
|
2015
Q2 | $5.18M | Sell |
41,962
-941
| -2% | -$116K | 0.08% | 312 |
|
|
2015
Q1 | $5.06M | Buy |
42,903
+513
| +1% | +$60.5K | 0.08% | 304 |
|
|
2014
Q4 | $5.04M | Sell |
42,390
-4,615
| -10% | -$548K | 0.08% | 297 |
|
|
2014
Q3 | $5.28M | Sell |
47,005
-917
| -2% | -$103K | 0.09% | 273 |
|
|
2014
Q2 | $4.54M | Buy |
47,922
+3,255
| +7% | +$308K | 0.09% | 286 |
|
|
2014
Q1 | $3.16M | Sell |
44,667
-7,691
| -15% | -$544K | 0.07% | 314 |
|
|
2013
Q4 | $3.89M | Buy |
52,358
+20,358
| +64% | +$1.51M | 0.1% | 262 |
|
|
2013
Q3 | $2.43M | Sell |
32,000
-5,000
| -14% | -$379K | 0.08% | 263 |
|
|
2013
Q2 | $2.96M | Buy |
+37,000
| New | +$2.96M | 0.1% | 229 |
|